FinLnq
ABOUT FINLNQ
Built for the Financial Realities of Drug Development
Biotech companies operate in an environment where capital, timing, and execution are closely connected. The right financial leadership helps extend runway, support critical decisions, and prepare the company for what comes next.
FinLnq provides experienced finance and accounting professionals who understand the demands of drug development, fundraising, forecasting, reporting, and financial operations.
From fractional and interim leadership to project support and permanent hires, we help biotech companies build the finance function they need at each stage of development.
How We Work
The right level of finance expertise.
Biotech companies rarely need the same finance and accounting structure at every stage of drug development. FinLnq provides experienced professionals who can lead, build, or execute based on what the business requires today.
What We Support
From runway and forecasting to close, reporting, and capital planning.
Our professionals work across CFO leadership, Controller support, FP&A, accounting operations, budgeting, forecasting, board reporting, and fundraising preparation.
Why Choose FinLnq
Because biotech finance is different.
Drug development shapes how companies plan, spend, hire, and raise capital. FinLnq brings professionals who understand that environment and can contribute without needing to learn the industry first.
BIOTECH FINANCE & ACCOUNTING SUPPORT
Experienced support across the finance function, from day-to-day execution to strategic financial leadership.
FinLnq supports biotech companies across accounting, FP&A, Controller, and CFO-level needs, including close and reporting, budgeting and forecasting, runway and capital planning, board and investor reporting, fundraising preparation, and finance infrastructure.
.jpg)
.jpg)
.jpg)
SERVING INDUSTRY LEADERS
Our Valued Partners
OUR VISION
To be the most trusted partner for accounting and finance leaders, recognized for strengthening financial operations, ensuring accuracy and accountability, and building high-performing teams that support long-term, sustainable growth.
FLEXIBLE ENGAGEMENT MODELS
Finance expertise structured around what the company needs now.
Biotech finance needs change as programs advance, capital is raised, and organizations grow. FinLnq can provide leadership and execution for a defined period, support a specific finance initiative, or help build the permanent team.
Fractional & Interim Leadership
Experienced CFO, Controller, and finance leaders who can step into an active leadership need without requiring a full-time hire.
Project & Embedded Support
FP&A, accounting, reporting, modeling, systems, and other finance expertise for specific initiatives or ongoing execution.
Permanent Finance Talent
Targeted search for CFO, Controller, FP&A, accounting, and senior finance professionals who understand the biotech environment.
Engagements can scale or change as the company’s needs evolve.
WHAT OUR CLIENTS SAYS ABOUT
FinLnq
This is your Testimonial section paragraph. It’s a great place to tell users how much you value your customers and their feedback.
Alex Smith
Client Review
This is your Testimonial section paragraph. It’s a great place to tell users how much you value your customers and their feedback.
Drew Carlyle
Client Review
This is your Testimonial section paragraph. It’s a great place to tell users how much you value your customers and their feedback.
Charlie McMann
Client Review
WHY CHOOSE FINLNQ
The right finance expertise at every stage of drug development.
-
Biotech Finance Experience
Professionals who understand runway, financing cycles, development milestones, and the financial demands of drug development.
-
Leadership Through Execution
CFO and Controller leadership backed by hands-on FP&A, accounting, reporting, and operational support.
-
Flexible Engagement
Fractional, interim, project-based, or permanent support based on what the company needs now.
-
Built to Scale
Support can expand, contract, or change as programs, capital needs, and financial complexity evolve.
